The increasing complexity of oncology treatment necessitates a thorough understanding of diverse healthcare approaches. This article aims to explore the benefits and limitations of transatlantic cancer care, contrasting the clinical pathways in both the United States and the European Union. Through a multifaceted lens, we will assess key dimensions